HIV and hepatitis delta virus: evolution takes different paths to relieve blocks in transcriptional elongation - PubMed

Review

HIV and hepatitis delta virus: evolution takes different paths to relieve blocks in transcriptional elongation

Yuki Yamaguchi et al. Microbes Infect. 2002 Sep.

Free article

Abstract

The elongation step of transcription by RNA polymerase II (RNAPII) is controlled both positively and negatively by over a dozen cellular proteins. Recent findings suggest that two distinct viruses, human immunodeficiency virus type 1 and hepatitis delta virus, encode proteins that facilitate viral replication and transcription by targeting the same cellular transcription elongation machinery.

Similar articles

• A new paradigm in eukaryotic biology: HIV Tat and the control of transcriptional elongation.

  Barboric M, Peterlin BM. Barboric M, et al. PLoS Biol. 2005 Feb;3(2):e76. doi: 10.1371/journal.pbio.0030076. PLoS Biol. 2005. PMID: 15719065 Free PMC article.

• Stimulation of RNA polymerase II elongation by hepatitis delta antigen.

  Yamaguchi Y, Filipovska J, Yano K, Furuya A, Inukai N, Narita T, Wada T, Sugimoto S, Konarska MM, Handa H. Yamaguchi Y, et al. Science. 2001 Jul 6;293(5527):124-7. doi: 10.1126/science.1057925. Epub 2001 May 31. Science. 2001. PMID: 11387440

• Modulating HIV-1 replication by RNA interference directed against human transcription elongation factor SPT5.

  Ping YH, Chu CY, Cao H, Jacque JM, Stevenson M, Rana TM. Ping YH, et al. Retrovirology. 2004 Dec 27;1:46. doi: 10.1186/1742-4690-1-46. Retrovirology. 2004. PMID: 15620346 Free PMC article.

• Tackling Tat.

  Karn J. Karn J. J Mol Biol. 1999 Oct 22;293(2):235-54. doi: 10.1006/jmbi.1999.3060. J Mol Biol. 1999. PMID: 10550206 Review.

• Tat, Tat-associated kinase, and transcription.

  Jeang KT. Jeang KT. J Biomed Sci. 1998;5(1):24-7. doi: 10.1007/BF02253352. J Biomed Sci. 1998. PMID: 9570510 Review.

Cited by

• DSIF, the Paf1 complex, and Tat-SF1 have nonredundant, cooperative roles in RNA polymerase II elongation.

  Chen Y, Yamaguchi Y, Tsugeno Y, Yamamoto J, Yamada T, Nakamura M, Hisatake K, Handa H. Chen Y, et al. Genes Dev. 2009 Dec 1;23(23):2765-77. doi: 10.1101/gad.1834709. Genes Dev. 2009. PMID: 19952111 Free PMC article.

• Prevalence of hepatitis d in the eastern mediterranean region: systematic review and meta analysis.

  Amini N, Alavian SM, Kabir A, Aalaei-Andabili SH, Saiedi Hosseini SY, Rizzetto M. Amini N, et al. Hepat Mon. 2013 Jan;13(1):e8210. doi: 10.5812/hepatmon.8210. Epub 2013 Jan 6. Hepat Mon. 2013. PMID: 23554822 Free PMC article.

• Recombinant identification, molecular classification and proposed reference genomes for hepatitis delta virus.

  Miao Z, Zhang S, Ma Z, Hakim MS, Wang W, Peppelenbosch MP, Pan Q. Miao Z, et al. J Viral Hepat. 2019 Jan;26(1):183-190. doi: 10.1111/jvh.13010. Epub 2018 Oct 19. J Viral Hepat. 2019. PMID: 30260538 Free PMC article.

• Origin of RNA Polymerase II pause in eumetazoans: Insights from Hydra.

  Reddy PC, Pradhan SJ, Karmodiya K, Galande S. Reddy PC, et al. J Biosci. 2020;45:8. doi: 10.1007/s12038-019-9979-y. J Biosci. 2020. PMID: 31965986 Free PMC article.

• RNA replication without RNA-dependent RNA polymerase: surprises from hepatitis delta virus.

  Lai MM. Lai MM. J Virol. 2005 Jul;79(13):7951-8. doi: 10.1128/JVI.79.13.7951-7958.2005. J Virol. 2005. PMID: 15956541 Free PMC article. Review. No abstract available.

Publication types

MeSH terms

Substances